Roche to acquire digital pathology firm PathAI in deal potentially worth over $1B

Roche to acquire digital pathology firm PathAI in deal potentially worth over $1B is a pharma and life sciences industry update from BioPharma Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Elise Reuter · 2026-05-07

Roche plans to offer PathAI’s tools as part of an effort to improve cancer diagnosis and tailored treatment.

Source: BioPharma Dive